Aug 27, 2024 · Vitreomacular traction (VMT) occurs when vitreous in the aging eye doesn’t detach completely from the macula. VMT can cause vision loss if left untreated.

Ocriplasmin (Jetrea®), a recombinant truncated form of human plasmin, is a pharmacologic option for treating VMT syndrome. Clinical trials demonstrated the efficacy and safety of a …

Vitreomacular traction (VMT) syndrome is a potentially visually significant disorder of the vitreoretinal interface characterized by an incomplete posterior vitreous detachment with the …

May 1, 2023 · Vitreomacular traction is a condition that affects the macula and, if left untreated, could lead to severe vision problems.

Abstract The paper presents a review of the sequence of events of posterior vitreous detachment (PVD), vitreomacular adhesion (VMA), vitreomacular traction (VMT), and macular hole (MH) …

Feb 13, 2025 · Vitreomacular traction can result in various sequelae, ranging from mild to severe. With continued advances in disease classification, patient stratification has become a key …

Initially, it usually occurs with vitreo-macular attachment (VMA) before separation but can be complicated by vitreo-macular traction (VMT) which can cause a macular hole. This Clinical …

Published April 16, 2010 When to Monitor or Treat VMT Cases of vitreomacular traction progress very differently, so keep a close eye on your patient. Captain Christopher M. Putnam, O.D., …

Jan 20, 2025 · Vitreomacular traction (VMT) is characterised by abnormal adhesion of the posterior cortical vitreous with the macula causing distortion of the foveal contour and …

What is vitreomacular traction? Vitreomacular traction (VMT) is a condition in which a posterior vitreous detachment occurs but the separation is incomplete, leaving the persistently attached …